Pros | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | 2/8 | 1/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Years | 12 Years | ||
Fund Size | 5508 Cr | 3689 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹500 Lumpsum ₹5000 | ||
Expense Ratio | 1.06% | 0.9% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 41 | 32 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.66%) Dr Reddy's Laboratories Ltd (9.66%) Divi's Laboratories Ltd (9.03%) Cipla Ltd (7.85%) Aurobindo Pharma Ltd (6.34%) | Sun Pharmaceuticals Industries Ltd (12.73%) Divi's Laboratories Ltd (7.39%) Max Healthcare Institute Ltd Ordinary Shares (6.4%) Lonza Group Ltd ADR (4.81%) Cipla Ltd (4.77%) | ||
No of Sectors | 3 | 2 | ||
Top 3 Sectors | Health (94.88%) Basic Materials (3.81%) Financial Services (1.31%) | Health (93.74%) Basic Materials (6.26%) | ||
Equity % | 96.99% | 96.08% | ||
Debt % | - | - | ||
P/E | 30.46 | 42.92 | ||
P/B | 4.13 | 6.01 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 4.43% | 4.75% | ||
3-Month Return | 13.64% | 9.74% | ||
6-Month Return | 0.44% | -0.13% | ||
1-Year Return | 22% | 21.86% | ||
3-Year Return | 31.44% | 31.11% | ||
5-Year Return | 26.05% | 26.05% |
Sharpe | 1.43 | 1.57 | ||
Alpha | 3.56 | 5.16 | ||
Beta | 0.94 | 0.84 | ||
Standard Deviation | 15.37 | 13.71 | ||
Information Ratio | 1.04 | 0.71 |
Description | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dharmesh Kakkad | Tanmaya Desai |